Biogen Exits Joint Venture As Samsung Biologics Buys Out Bioepis
Sale Price Of $2.3bn To Be Paid Over Next Two Years
Executive Summary
Biogen’s stake in Samsung Bioepis has been fully acquired by former partner Samsung Biologics, following an announcement of the deal in January.